Cost-effectiveness of entecavir versus lamivudine for the suppression of viral replication in chronic hepatitis B Patients in Brazil

Hepatitis B virus infection is an important public-health issue. Chronic patients have a higher risk of death due to complications, which increases health-care expenses in. Cost-effectiveness analysis of entecavir (ETV) versus lamivudine (LVD) for treatment of chronic hepatitis B, in e antigen (AgHB...

Full description

Bibliographic Details
Main Author: Costa,Anna Maria N. (author)
Other Authors: L.'Italien,Gilbert (author), Nita,Marcelo Eidi (author), Araujo,Evaldo Stanislau A. (author)
Format: article
Language:eng
Published: 2008
Subjects:
Chronic hepatitis B
cost
treatment
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702008000500005
Country:Brazil
Oai:oai:scielo:S1413-86702008000500005

Internet

http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702008000500005

Similar Items